Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aplidin enters phase I for pediatric solid tumors and hematological malignancies

March 25, 2004

Novel antitumor protein kinase inhibitors under study at Abbott

March 25, 2004

New polymeric cytotoxic agents developed by Sankyo scientists

March 25, 2004

CCI-779 demonstrates activity in renal cell carcinoma

March 24, 2004

Ecteinascidin-743 induces disease control in soft tissue sarcoma patients

March 24, 2004

Tellurium compound, AS-101, is a potential treatment for alopecia

March 24, 2004

U. of Missouri-Columbia Research Reactor Center to supply holmium-166 to NeoRx

March 24, 2004

Astex presents two series of CDK2 inhibitors for cancer, fungal infections, etc.

March 24, 2004

Antisoma updates progress of two anticancer drug candidates

March 23, 2004

New phase II study investigates Tarceva in poor performance NSCLC patients

March 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...